Page last updated: 2024-11-05

thalidomide and Vaginal Neoplasms

thalidomide has been researched along with Vaginal Neoplasms in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Vaginal Neoplasms: Tumors or cancer of the VAGINA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zwart, D1
Napalkov, NP1

Reviews

1 review available for thalidomide and Vaginal Neoplasms

ArticleYear
[Transplacental carcinogenesis].
    Vestnik Akademii meditsinskikh nauk SSSR, 1977, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Abnormalities, Drug-Induced; Adenocarcinoma; Animals; Carcinogens;

1977

Other Studies

1 other study available for thalidomide and Vaginal Neoplasms

ArticleYear
[Clinical observations in the influence of thalidomide in the treatment of a leiomyoma in a dog].
    Arzneimittel-Forschung, 1966, Volume: 16, Issue:12

    Topics: Animals; Dogs; Female; Leiomyoma; Thalidomide; Vaginal Neoplasms

1966